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Abstract—A total synthesis of the ‘putative structure’ 7, attributed to the novel triquinane sesquiterpene isolated recently from two
Buddelia species has been accomplished. The spectral data for 7 is a complete mismatch with those reported for the natural
product and warrants a revision of the assigned structure. 
In recent years, the number of linearly-fused triquinane
sesquiterpenoids based on the tricyclo[6.3.0.02,6]-
undecane skeleton 1 has been gradually swelling. These
natural products display variation in the disposition of
methyl groups and level of functionalization, while
embodying the basic framework 1. Notable examples of
different skeletal types among triquinane natural prod-
ucts are coriolin 2 (hirsutane type), cucumin E 3 (isohir-
sutane type), ceratopicanol 4 (ceratopicane type),
pleurotellol 5 (pleurotellane type) and capnellene 6
(capnellane type).1 Triquinane natural products, many
of which exhibit impressive biological activity, have
aroused a great deal of synthetic interest during the
past two decades.1,2 In 1995, Romo de Vivar et al.
added a new skeletal-type to the triquinane natural
products and reported the isolation of isocapnell-9-en-
8-one 7 and 6-hydroxyisocapnell-9-en-8-one 8 from
widely occurring plants Buddleia cordata and Buddleia
sessiliflora H. B. K. used in traditional medicine in
different regions of the world.3 Stereostructures of these
novel triquinanes 7 and 8 were deduced through exten-
sive 1H and 13C NMR (COSY, HETCOR, COLOC,
NOESY) experiments. As 7 and 8 are closely related to
capnellanes 6 through the migration of the angular
methyl group, the new triquinane skeleton was termed
as isocapnellane.3 It was also surmised that the isocap-
nellane skeleton need not be derived through methyl
migration in an appropriate capnellane precursor but
can be formed directly from humulene oxide through
the intermediacy of the sesquiterpene africanol.3
In view of our long-standing interest4 in the synthesis of
triquinane natural products, isocapnellane structures 7
and 8 attracted our attention. We report here a total
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synthesis of tricyclic enone 7, the structure assigned to
the natural product, isocapnell-9-en-8-one, following a
variant of the photo-thermal metathesis strategy
described by us sometime ago for the synthesis of linear
triquinanes.4a,b However, we find that the spectral char-
acteristics of the putative structure 7, synthesized here
through an unambiguous route, differ completely from
the data reported for the natural product.
Pentacyclic dione 9,5 readily available from 1,2,3,4-tet-
rachloro-5,5-dimethoxycyclopentadiene and p-benzo-
quinone in two steps served as the starting point and
was elaborated to the cis,anti,cis-fused triquinane bis-
enone 10 as described recently by us.4h Catalytic hydro-
genation of 10 to 11 and selective mono-Wittig
olefination furnished 12 (Scheme 1).6 Simmons–Smith
cyclopropanation of 12 in the presence of diethylzinc7
proceeded modestly and resulted in simultaneous
deprotection of the dimethylacetal moiety to yield the
saturated tricyclic dione 13. The two carbonyl function-
alities in 13 now needed to be differentiated and after
some attempts we found that the C9 carbonyl group
could be regioselectively protected as the 2,2-dimethyl-
1,3-dioxane derivative 146 (Scheme 1).
At this stage, the C5 carbonyl functionality in 14
needed to be transformed into a secondary methyl
group with the requisite stereochemistry. Towards this
end, 14 was subjected to Wittig olefination to furnish
15. Catalytic hydrogenation of 15, as expected, was
non-stereoselective and led to a nearly 1:1 mixture of
diastereomers 16 and 17 (Scheme 1). While the two
diastereomers were readily separable by chromatogra-
phy, unambiguous assignment of the stereochemistry of
Scheme 1. Reagents and conditions : (a) see Ref. 5; (b) H2, 10% Pd/C,1 atm., EtOAc, rt, 1 h, quant.; (c) PPh3+CH3Br−, tBuO−K+,
benzene, 5°C, 90–95% at 60% conversion; (d) Et2Zn, CH2I2, DCE, 0°C–rt, 18 h, 50–55%; (e) 2,2-dimethylpropanediol, PPTS,
benzene, reflux, 8 h, 80–85%; (f) PPh3
+CH3Br
−, tBuO−K+, benzene, reflux, 2 h, 85–90%; (g) H2, 10% Pd/C,1 atm., EtOAc, rt, 1
h, 16:17 1:1, quant.
Figure 1.
Scheme 2. Reagents and conditions : (a) Amberlyst-15, aq. acetone, 30 min, quant.; (b) PtO2, H2, 50 psi, AcOH, 18–24 h, 70% ;
(c) PPh3
+CH3Br
−, tBuO−K+, benzene, rt, 3 h, 75%; (d) (i) SeO2, DCM, TBHP, rt, 5 h, 65%, (ii) MnO2, DCM, rt, 6 h, 75%; (e)
PTSA, benzene, reflux, 8 h, 65–70%.
the methyl group at C5 in 16 and 17 from spectroscopic
data alone proved difficult and was settled through the
X-ray crystal structure determination of a derivative of
16 (Fig. 1).8
The diastereomer 17 having the requisite C5 methyl
stereochemistry was first taken through the synthesis.
Ketal deprotection in 17 led to the ketone 18 and now
the spiro-fused cyclopropane ring, which had been posi-
tioned as a latent gem-dimethyl group, was subjected to
hydrogenolysis to furnish 19 (Scheme 2).6 The stage
was now set for the generation of the enone moiety and
the introduction of the last carbon atom en route to 7.
Wittig olefination in 19 proceeded smoothly to furnish
20. To introduce the C8 carbonyl functionality, 20 was
subjected to catalytic selenium dioxide oxidation to
furnish the corresponding allylic alcohol and further
oxidized with manganese dioxide to the enone 21
(Scheme 2).6 On exposure to acid catalysis, the exo-
cyclic double bond in 21 isomerized to the tetra-
substituted position and yielded 7 corresponding to the
structure assigned to the natural product.3 However,
the spectral data (UV, IR, 1H and 13C NMR) for 7 did
not match with those reported for the natural
product.3,6 The 2,4-dinitrophenylhydrazone (2,4-DNP)
derivative 22 prepared from 7 was also a mismatch with
the reported derivative. At this stage, to establish fully
the error of the assigned structure of the natural
product, we carried out an X-ray crystal structure
determination on 22 and the ORTEP diagram is pre-
sented in Fig. 2.9
Since our synthetic product 7 was not identical with the
natural product, our instinctive feeling was to consider
the diastereomeric formulation 23 (C5 epimer) as a
possible alternative structure for the natural product.
With these thoughts in mind, we proceeded to elaborate
the C5 epimeric ketal 16 to 23 (Scheme 3). Ketal
deprotection in 16 furnished ketone 24 and was sub-
jected to hydrogenolysis to deliver the gem-dimethyl-
ated product 25 (Scheme 3). Wittig olefination in 25 led
to 26 and generated the C15-framework. The carbonyl
functionality at C8 in 26 was installed in a two step
sequence involving allylic hydroxylation and oxidation
to furnish enone 27. Finally, acid mediated isomeriza-
tion in 27 led to the targeted structure 23 (Scheme 3).
Once again, we found that the spectral characteristics
of 23 were completely at variance with those of the
natural product but closely resembled that of putative
structure 7.
In summary, we have achieved a total synthesis of the
putative structure 7 assigned to the natural product
isocapnell-9-en-8-one. We have also outlined a synthe-
sis of 23, the C5 epimer of 7. We find that the spectral
data for both 7 and 23 are very different from those of
the natural product.3 These observations and a careful
scrutiny of the reported spectral data leads to the
surmise that the natural products 7 and 8 reported3
from B. cordata and B. sessiliflora H. B. K. do not
possess a novel triquinane framework and their struc-
ture revision is mandated.10
Figure 2.
Scheme 3. Reagents and conditions : (a) Amberlyst-15, aq. acetone, 30 min, quant.; (b) PtO2, H2, 50 psi, AcOH, 18–24 h, 70% ;
(c) PPh3
+CH3Br
−, tBuO−K+, benzene, rt, 3 h, 70–75%; (d) (i) SeO2, DCM, TBHP, rt, 5 h, 60%, (ii) MnO2, DCM, rt, 6 h, 75–80%;
(e) PTSA, benzene, reflux, 8 h, 65–70%.
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